CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 50 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,108,205 | +15.6% | 325,843 | +10.6% | 0.00% | – |
| Q2 2023 | $1,822,955 | +61.8% | 294,500 | +0.6% | 0.00% | – |
| Q1 2023 | $1,126,741 | +17.2% | 292,660 | -5.6% | 0.00% | – |
| Q4 2022 | $961,127 | -18.5% | 310,041 | +5.6% | 0.00% | – |
| Q3 2022 | $1,180,000 | -19.7% | 293,511 | -2.8% | 0.00% | – |
| Q2 2022 | $1,470,000 | -40.7% | 301,915 | +9.2% | 0.00% | – |
| Q1 2022 | $2,481,000 | -23.3% | 276,518 | -3.7% | 0.00% | – |
| Q4 2021 | $3,234,000 | +2840.0% | 287,238 | +5654.0% | 0.00% | – |
| Q2 2021 | $110,000 | – | 4,992 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Life Associates VI Ltd | 9,961,789 | $112,170,000 | 100.00% |
| Medicxi Ventures Management (Jersey) Ltd | 18,123,892 | $204,075,000 | 51.07% |
| Vida Ventures Advisors, LLC | 3,931,818 | $44,272,000 | 16.56% |
| OUP Management Co., LLC | 2,341,891 | $26,370,000 | 11.89% |
| Samsara BioCapital, LLC | 1,459,693 | $16,436,000 | 3.19% |
| VR Adviser, LLC | 1,127,272 | $12,693,000 | 1.74% |
| Affinity Asset Advisors, LLC | 419,144 | $4,720,000 | 1.71% |
| Cormorant Asset Management, LP | 2,489,894 | $28,036,000 | 1.67% |
| Kynam Capital Management, LP | 239,041 | $2,692,000 | 1.44% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $109,017,000 | 0.84% |